Clinical Trial: A Study to Investigate the Effects of JMKX003142 on QTc Interval in Healthy Adults

U.S., March 14 -- ClinicalTrials.gov registry received information related to the study (NCT07470177) titled 'A Study to Investigate the Effects of JMKX003142 on QTc Interval in Healthy Adults' on March 10.

Brief Summary: The primary objective of this study is to assess the effect of a therapeutic and supratherapeutic oral dose of JMKX003142 on the corrected cardiac QT interval relative to a placebo in healthy participants

Study Start Date: March 27

Study Type: INTERVENTIONAL

Condition: ADPKD (Autosomal Dominant Polycystic Kidney Disease)

Intervention: DRUG: JMKX003142 tablets

Participants will receive single of JMKX003142 6mg

DRUG: JMKX003142 tablets

Participants will receive single of JMKX003142 30mg

DRUG: Placebo

Participants...